CN101104069A - Traditional Chinese medicine formula for treating liver (biliary) inflammation - Google Patents
Traditional Chinese medicine formula for treating liver (biliary) inflammation Download PDFInfo
- Publication number
- CN101104069A CN101104069A CNA2007100150263A CN200710015026A CN101104069A CN 101104069 A CN101104069 A CN 101104069A CN A2007100150263 A CNA2007100150263 A CN A2007100150263A CN 200710015026 A CN200710015026 A CN 200710015026A CN 101104069 A CN101104069 A CN 101104069A
- Authority
- CN
- China
- Prior art keywords
- radix
- liver
- inflammation
- gallbladder
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention relates to a herbal prescription for treating the liver (gallbladder) inflammation in the traditional Chinese medicine preparation field. The technique proposal is that: the invention includes materials with parts by following weights: eight to twelve parts of bupleurum, twelve to fifteen parts of each of white peony root (stir-fried), hovenia dulcis, immature orange fruit, endothelium corneum gigeriae, nutgrass galingale rhizome, turmeric root tuber, ginseng root, prunella, Chinese angelica and absinthin, ten to twelve parts of giant knotweed rhizome, and three to five parts of liquorice. The invention has effects of relieving liver Qi stagnation and stagnation eliminating and blood stasis removing. The effective rate and the cure rate of the invention for treating the chronic hepatitis, hepatocirrhosis, chronic cholecystitis, cholelithiasis and pathological changes such as pain in chest and hypochondrium caused by liver Qi stagnation and Qi stagnation and blood stasis are respectively ninety two percent and eighty seven percent.
Description
Technical field
The present invention relates to the Chinese medicinal formulae of a kind of treatment liver (gallbladder) inflammation of field of traditional Chinese.
Background technology
At present the drug main of treatment chronic hepatitis, liver cirrhosis, chronic cholecystitis, cholelithiasis and the pathological changes such as pain in chest and hypochondrium that cause because of depression of liver-QI, qi depression to blood stasis will be based on Western medicine antibiotic medicine class, and the western medicine side effect is bigger, and easily recurrence; The treatment by Chinese herbs kind is few, and treatment cycle is long, and curative effect is low and slow.
Summary of the invention
Purpose of the present invention is exactly the defective that exists at prior art, and the Chinese medicinal formulae of little treatment liver (gallbladder) inflammation of a kind of good effect, side effect is provided.The raw material that comprises following weight portion is formed: Radix Bupleuri 8-12, each 12-15 of Radix Paeoniae Alba (parched), Fructus Aurantii, Fructus Aurantii Immaturus, Endothelium Corneum Gigeriae Galli, Rhizoma Cyperi, Radix Curcumae, Radix Ginseng, Spica Prunellae, Radix Angelicae Sinensis and Herba Artemisiae Scopariae, Rhizoma Polygoni Cuspidati 10-12, Radix Glycyrrhizae 3-5.
At chronic hepatitis patient, comprise also in the such scheme that the raw material of following weight portion is formed: each 10-12 of Herba Patriniae, Herba Sedi, Fructus Schisandrae Chinensis, Ganoderma and Fructus Lycii.
At liver cirrhosis patient, comprise also in the such scheme that the raw material of following weight portion is formed: each 10-12 of Ganoderma, Herba Patriniae, Fructus Lycii, Rhizoma Atractylodis Macrocephalae (parched), Radix Astragali, water tinctorius seed and Stigma Maydis.
At the cholecystitis patient, comprise also in the such scheme that the raw material of following weight portion is formed: each 10-12 of Herba Taraxaci, Herba Patriniae, Radix Scutellariae, FLOS MUME and Pericarpium Citri Reticulatae Viride.
At the cholelithiasis patient, comprise also in the such scheme that the raw material of following weight portion is formed: each 8-10 of Herba Lysimachiae, Semen Arecae, the Radix Aucklandiae, Radix Et Rhizoma Rhei, Semen Vaccariae and Radix Clematidis.
The present invention has dispersing the stagnated live-QI to relieve the stagnation of QI, the effect of stagnant removing blood stasis disappears.The Radix Bupleuri bar reaches irritability and stagnation resolving in the side, dredges sharp liver and gall and removes stagnant heat.Radix Paeoniae Alba nourishing blood to suppress the hyperactive liver and battalion's yin fluid astringing, relieving spasm to stop pain is also used then coordination of potent and mild therapies with Radix Bupleuri, is association of activity and inertia.The slow power of Fructus Aurantii property is little, and circulation of qi promoting is coerced diaphragm soon in breast but relieving distension is full; The impatient power of Fructus Aurantii Immaturus is strong, the circulation of qi promoting the turbid descending, and the painful abdominal mass that disappears is loose long-pending; Fructus Aurantii, Fructus Aurantii Immaturus and usefulness, the circulation of qi promoting painful abdominal mass that disappears, its benefit is clear.Rhizoma Cyperi is a disorder of QI Directorate-General DG, activating QI to alleviate the depression, and stagnant dissipating blood stasis disappears.Endothelium Corneum Gigeriae Galli is the activating the spleen master product that help digestion, and can remove expand lead long-pending, the dissipating blood stasis fossil; Two medicines, 5 usefulness are to qi and blood stagnation, and distension painful abdominal mass calculus curative effect is very good.The Radix Curcumae promoting the function of the gallbladder to alleviate jaundice, the removing blood stasis pain relieving, the stasis of blood of controlling breast abdomen side of body rib partially stagnates.Radix Ginseng, Spica Prunellae, the Radix Angelicae Sinensis blood circulation promoting competent silt, clearing heat and relieving fidgetness, the blood vessels of kind logical whole body, its energy anti-hepatic fibrosis promotes liver cell regeneration.Herba Artemisiae Scopariae is slightly cold, hepatic cholagogic, and removing damp-heat, the jaundice eliminating detoxifcation is treatment liver-gallbladder disease key medicine.Rhizoma Polygoni Cuspidati is gone into the liver and gall warp, and removing blood stasis is invigorated blood circulation, the function of gallbladder promoting detoxifcation.The Radix Glycyrrhizae liver detoxification, relieving spasm to stop pain, peace and the five internal organs are coordinated all medicines.The effective percentage 92% of the pathological changes such as pain in chest and hypochondrium that cause to chronic hepatitis, liver cirrhosis, chronic cholecystitis, cholelithiasis and because of depression of liver-QI, qi depression to blood stasis, cure rate 87%.
The specific embodiment
Enumerate embodiment below and be further described (each embodiment disposes with daily dosage):
Embodiment 1: Radix Bupleuri 8g, Radix Paeoniae Alba (parched) 12g, Fructus Aurantii 12g, Fructus Aurantii Immaturus 12g, Endothelium Corneum Gigeriae Galli 12g, Rhizoma Cyperi 12g, Radix Curcumae 12g, Radix Ginseng, Spica Prunellae, Radix Angelicae Sinensis 12g, Herba Artemisiae Scopariae 12g, Rhizoma Polygoni Cuspidati 10g, Radix Glycyrrhizae 3g.
Embodiment 2: at chronic hepatitis patient, on the basis of embodiment 1, increase Herba Patriniae, Herba Sedi, Fructus Schisandrae Chinensis, Ganoderma and each 10g of Fructus Lycii.
Embodiment 3: at liver cirrhosis patient, on the basis of embodiment 1, increase Ganoderma, Herba Patriniae, Fructus Lycii, Rhizoma Atractylodis Macrocephalae (parched), Radix Astragali, water tinctorius seed and each 10g of Stigma Maydis.
Embodiment 4: at the cholecystitis patient, on the basis of embodiment 1, increase Herba Taraxaci, Herba Patriniae, Radix Scutellariae, FLOS MUME and each 10g of Pericarpium Citri Reticulatae Viride.
Embodiment 5: at the cholelithiasis patient, on the basis of embodiment 1, increase Herba Lysimachiae, Semen Arecae, the Radix Aucklandiae, Radix Et Rhizoma Rhei, Semen Vaccariae and each 8g of Radix Clematidis.
Adopt prescription of the present invention can utilize existing manufacturing technique to prepare oral liquid or tablet, capsule etc., 1 dose of day clothes are respectively obeyed 1 time sooner or later.Usually it was a course of treatment with 10-15 days.
Claims (5)
1. the Chinese medicinal formulae of treatment liver (gallbladder) inflammation, it is characterized in that comprising the raw material composition of following weight portion: Radix Bupleuri 8-12, each 12-15 of Radix Paeoniae Alba (parched), Fructus Aurantii, Fructus Aurantii Immaturus, Endothelium Corneum Gigeriae Galli, Rhizoma Cyperi, Radix Curcumae, Radix Ginseng, Spica Prunellae, Radix Angelicae Sinensis and Herba Artemisiae Scopariae, Rhizoma Polygoni Cuspidati 10-12, Radix Glycyrrhizae 3-5.
2. the Chinese medicinal formulae of treatment according to claim 1 liver (gallbladder) inflammation is characterized in that the raw material that also comprises following weight portion forms: each 10-12 of Herba Patriniae, Herba Sedi, Fructus Schisandrae Chinensis, Ganoderma and Fructus Lycii.
3. the Chinese medicinal formulae of treatment according to claim 1 liver (gallbladder) inflammation is characterized in that the raw material that also comprises following weight portion forms: each 10-12 of Ganoderma, Herba Patriniae, Fructus Lycii, Rhizoma Atractylodis Macrocephalae (parched), Radix Astragali, water tinctorius seed and Stigma Maydis.
4. the Chinese medicinal formulae of treatment according to claim 1 liver (gallbladder) inflammation is characterized in that the raw material that also comprises following weight portion forms: each 10-12 of Herba Taraxaci, Herba Patriniae, Radix Scutellariae, FLOS MUME and Pericarpium Citri Reticulatae Viride.
5. the Chinese medicinal formulae of treatment according to claim 1 liver (gallbladder) inflammation is characterized in that the raw material that also comprises following weight portion forms: each 8-10 of Herba Lysimachiae, Semen Arecae, the Radix Aucklandiae, Radix Et Rhizoma Rhei, Semen Vaccariae and Radix Clematidis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007100150263A CN101104069A (en) | 2007-06-14 | 2007-06-14 | Traditional Chinese medicine formula for treating liver (biliary) inflammation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007100150263A CN101104069A (en) | 2007-06-14 | 2007-06-14 | Traditional Chinese medicine formula for treating liver (biliary) inflammation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101104069A true CN101104069A (en) | 2008-01-16 |
Family
ID=38998276
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2007100150263A Pending CN101104069A (en) | 2007-06-14 | 2007-06-14 | Traditional Chinese medicine formula for treating liver (biliary) inflammation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101104069A (en) |
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102727837A (en) * | 2012-07-23 | 2012-10-17 | 鲁道宗 | Traditional Chinese medicine prescription for treating cholelithiasis and chronic cholecystitis |
| CN102872362A (en) * | 2012-10-13 | 2013-01-16 | 郭伟华 | Traditional Chinese medicine for treating chronic cholecystitis |
| CN102973673A (en) * | 2012-12-06 | 2013-03-20 | 常熟富士莱医药化工有限公司 | Pharmaceutical preparation for treating hepatopyretic disease |
| CN103393979A (en) * | 2013-08-19 | 2013-11-20 | 张成娟 | Drug for curing cholecystitis |
| CN103393963A (en) * | 2013-07-20 | 2013-11-20 | 邵梅 | Traditional Chinese medicine composition for treating chronic cholecystitis |
| CN103599370A (en) * | 2013-11-14 | 2014-02-26 | 许丽娜 | Traditional Chinese medicine preparation for treating blood stasis type acute cholecystitis |
| CN105169278A (en) * | 2015-10-12 | 2015-12-23 | 青岛恒波仪器有限公司 | Dandelion oral liquid capable of protecting liver and benefiting gallbladder and preparation method thereof |
| CN105168878A (en) * | 2015-09-18 | 2015-12-23 | 马鞍山德宏堂生物科技有限公司 | Traditional Chinese medicine decoction for treating costalgia due to Qi stagnation and blood stasis |
| CN105169275A (en) * | 2015-10-12 | 2015-12-23 | 青岛恒波仪器有限公司 | Rheum officinale oral liquid capable of protecting liver and benefiting gallbladder and preparation method thereof |
| CN105168760A (en) * | 2015-08-14 | 2015-12-23 | 高伟 | Traditional Chinese medicine treating liver qi stagnation chronic cholecystitis and preparation method therefor |
| CN105193957A (en) * | 2015-10-30 | 2015-12-30 | 丁明辉 | Traditional Chinese medicine composition for treating liver cirrhosis |
| CN107551182A (en) * | 2017-10-27 | 2018-01-09 | 王彦春 | A kind of Chinese traditional compound medicine for being used to treat hepatic disorder |
| CN109498776A (en) * | 2017-09-14 | 2019-03-22 | 周春云 | Liver and gallbladder pancreas spleen ball |
| CN110179951A (en) * | 2019-06-28 | 2019-08-30 | 宗吉红 | A kind of Chinese medicine composition and preparation method thereof for recuperating under medical treatment virus hepatitis |
-
2007
- 2007-06-14 CN CNA2007100150263A patent/CN101104069A/en active Pending
Cited By (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102727837A (en) * | 2012-07-23 | 2012-10-17 | 鲁道宗 | Traditional Chinese medicine prescription for treating cholelithiasis and chronic cholecystitis |
| CN102872362A (en) * | 2012-10-13 | 2013-01-16 | 郭伟华 | Traditional Chinese medicine for treating chronic cholecystitis |
| CN102872362B (en) * | 2012-10-13 | 2014-01-22 | 初艳红 | Traditional Chinese medicine for treating chronic cholecystitis |
| CN102973673A (en) * | 2012-12-06 | 2013-03-20 | 常熟富士莱医药化工有限公司 | Pharmaceutical preparation for treating hepatopyretic disease |
| CN103393963A (en) * | 2013-07-20 | 2013-11-20 | 邵梅 | Traditional Chinese medicine composition for treating chronic cholecystitis |
| CN103393979A (en) * | 2013-08-19 | 2013-11-20 | 张成娟 | Drug for curing cholecystitis |
| CN103393979B (en) * | 2013-08-19 | 2015-02-25 | 张成娟 | Drug for curing cholecystitis |
| CN103599370A (en) * | 2013-11-14 | 2014-02-26 | 许丽娜 | Traditional Chinese medicine preparation for treating blood stasis type acute cholecystitis |
| CN105168760A (en) * | 2015-08-14 | 2015-12-23 | 高伟 | Traditional Chinese medicine treating liver qi stagnation chronic cholecystitis and preparation method therefor |
| CN105168878A (en) * | 2015-09-18 | 2015-12-23 | 马鞍山德宏堂生物科技有限公司 | Traditional Chinese medicine decoction for treating costalgia due to Qi stagnation and blood stasis |
| CN105169278A (en) * | 2015-10-12 | 2015-12-23 | 青岛恒波仪器有限公司 | Dandelion oral liquid capable of protecting liver and benefiting gallbladder and preparation method thereof |
| CN105169275A (en) * | 2015-10-12 | 2015-12-23 | 青岛恒波仪器有限公司 | Rheum officinale oral liquid capable of protecting liver and benefiting gallbladder and preparation method thereof |
| CN105193957A (en) * | 2015-10-30 | 2015-12-30 | 丁明辉 | Traditional Chinese medicine composition for treating liver cirrhosis |
| CN109498776A (en) * | 2017-09-14 | 2019-03-22 | 周春云 | Liver and gallbladder pancreas spleen ball |
| CN107551182A (en) * | 2017-10-27 | 2018-01-09 | 王彦春 | A kind of Chinese traditional compound medicine for being used to treat hepatic disorder |
| CN110179951A (en) * | 2019-06-28 | 2019-08-30 | 宗吉红 | A kind of Chinese medicine composition and preparation method thereof for recuperating under medical treatment virus hepatitis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101104069A (en) | Traditional Chinese medicine formula for treating liver (biliary) inflammation | |
| CN102178850B (en) | Medicament for treating headache | |
| CN102319407B (en) | Traditional Chinese medicine for treating gastroptosis and extraction method thereof | |
| CN1286518C (en) | Chinese medicinal prescription for treating gastropathy | |
| CN1421234A (en) | Oral liquid for treating hepatitis B | |
| CN105031307A (en) | Chinese drugs preparation for curing headache and preparation method for Chinese drugs pharmaceutics | |
| CN1103223C (en) | Chinese medicine for treating cholecystitis | |
| CN101518640A (en) | Chinese traditional medicine prescription for treating tumor | |
| CN103041203A (en) | Traditional Chinese medicine formula for treating chronic pyelonephritis | |
| CN102988616B (en) | Chinese medicinal composition for treating anemia | |
| CN104984248A (en) | Traditional Chinese medicinal compound for treating hepatitis | |
| CN101284113A (en) | Yin toxin Qingyuan pellet | |
| CN103623385B (en) | A kind of Chinese medicine for the treatment of oral ulcer | |
| CN101757206A (en) | Chinese medicine preparation for treating chronic colitis | |
| CN101152540A (en) | Chinese traditional medicine for treating chronic hepatitis | |
| CN103550679A (en) | Traditional Chinese medicine formula for treatment of lithangiuria | |
| CN102423441A (en) | Double-formula medicine used for treating constipation, and preparation method thereof | |
| CN101468169A (en) | Medicaments assembly for treating menorrhalgia and preparation thereof | |
| CN101658636A (en) | Chinese medical composition for treating coronary heart disease | |
| CN102240383B (en) | Traditional Chinese medicine composition for treating dysmenorrhea | |
| CN102309600A (en) | Traditional Chinese medicine prescription for treating acne rosacea | |
| CN105169253A (en) | Traditional Chinese medicine decoction for treating amenorrhea | |
| CN101032573B (en) | Medicine for treating psoriasis and its preparing process | |
| CN101455819B (en) | Nutrient health product for treating chronic hepatitis B | |
| CN1245205C (en) | Chinese medicine for treating alimentary system malignant tumour |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20080116 |